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ABSTRACT
The aim of this work was to take advantage of the electrospray technology and the
osteocompatibility of both chitosan and calcium phosphate (CaP) to fabricate chitosan coatings
loaded with CaP nanoshell particles. The key electrospray parameters of capillary diameter,
voltage, and pressure were identified and adjusted for creating uniform chitosan-CaP coatings on
titanium surfaces. Coatings containing from 0 to 1 wt% CaP particles to chitosan mass were
electrosprayed on to silanated titanium to create composite coatings bonded to the metal surface.
Scanning electron microscope (SEM) and energy dispersive X-ray spectroscopy (EDS) showed
that CaP particles were homogenously distributed throughout the chitosan coating. Mechanical
tensile testing demonstrated that there was no statistically significant loss of coating adhesion
strength up to 1.0 wt% incorporation of CaP particles. Furthermore, the incorporation of CaP
particles was shown to support growth of bone cells on the coating. We have demonstrated that
CaP particles can successfully be incorporated into electrosprayed chitosan coating.
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CHAPTER I
INTRODUCTION
Statement of Clinical Problem
Arthritis is the leading cause of disability among adults in the U.S. and, according to the
CDC, about 54 million adults in the United States have been diagnosed with arthritis.
Osteoarthritis is the most common type of arthritis, affecting an estimated 31 million Americans.
[1] Osteoarthritis occurs due to deterioration/degradation of the cartilage in the joint that can
ultimately lead to direct contact between articulating bones of the joint and causing severe pain
limiting mobility and function. [2] Arthritis is more common among people with other chronic
conditions and according to the CDC, after age-adjustment, adults who are obese, had diabetes,
or heart disease are approximately 1.5, 1.7, and 1.9 times more likely than those without the
corresponding condition to have arthritis. [1] Economic cost of arthritis are far-reaching,
affecting almost two-thirds of working age adults in the U.S. (18-64 years). According estimates
by the CDC in 2005 the total costs from arthritis and related rheumatic conditions were about
$128 billion. By the year 2040 it is expected that more than 78 million will be diagnosed with
arthritis in general making arthritis one of the leading causes of disability among adults in the
U.S. [1]
The initial treatments therapies for arthritis typically use medication to treat the
symptoms caused by the joint wear. Analgesics ease mild to moderate pain and Nonsteroidal
Anti-inflammatory Drugs (NSAIDs) relieve pain and inflammation. While helpful in treating the
symptoms of arthritis, these drugs do not address the degradation of the joints. [3] In patients
with severe cartilage loss/damage, and ongoing pain, limited function and diminished life
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quality, biomedical total joint implant devices have become a reliable and effective means for
replacing and restoring joint function. [4]
Total joint devices are typically composed of metal components, that are implanted into
bone and metal, polymer or ceramic components to provide articulation of the devices. Figure 1
shows the components of a total hip device. Ti-based alloys such as Ti-6Al-4V widely used for
the components implanted into due to their high corrosion resistance, biocompatibility and since
their modulus is closer to that of native bone to reduce stress shielding. [5] Articulating
components of total joint devices are commonly composed of Co-Cr alloys due to their high
hardness and wear resistance and UHMWPE due to its low coefficient of friction. [6,7] In total
joint devices like total hip and shoulder replacements that have a ball-and socket type joint, high
strength ceramic materials like alumina can be used for the articulating components. [8]

Figure 1. Parts of a total hip replacement. A) The titanium femoral stem. B) Co-Cr femoral head.
C) UHMWPE articulation surface. D) Titanium acetabular cup
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While most implants will perform well over the span of 15-20 years about 5% of
implants will suffer some type of failure. [1] The most common causes of total joint replacement
(TJR) failure include polyethylene wear, infection, and implant component loosening. [9,10]
Polyethylene particles come from wear debris from the lining of the joint articulating surface the
or how they occur, and their accumulation in adjacent tissues leads to inflammatory processes
leading to bone resorption and implant failure. Implant associated infections are a serious
condition that leads to inflammatory responses, poor healing, or loss of integration of implants in
the bone. Bacteria are then able colonize implant surfaces, create biofilms leading to implant
associated infections. Bones can become infected in several ways: Infection in one part of the
body may spread through the bloodstream onto the implant, or an open fracture or surgery may
expose the bone and implant devices.
According Kim, Kyung Tae, et al. implant associated infections account for 26-40% of
implant failures depending on the age group of the patients. Infection-related failures of total
knee replacements (TKR) typically occurring within 2 years of implantation. [3] It was also
found that there were higher failure rates of aseptic loosening in young patients which may be
associated with the higher level of activities and functional demands, and longer remaining life
expectancy in young patients. [3] In the case of other total joint replacements, in 2004 it was
reported that of the over 250,000 THRs performed in the US, 94% were performed for
osteoarthritis. [11] Deep infection occurred in around 0.5–2% of total hip replacements (THR)
and was the cause for revision surgery in at least 7.5% of failures. Infection is more common in
inflammatory arthritis, psoriatic arthritis, patients taking corticosteroid treatment, chronic renal
failure, diabetes mellitus, high risk surgical patients, malnutrition, and older age. [1] This can be
attributed to the formation of biofilms and the possibility of compromised immune system of the
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patient. [4] However, the most common cause of revision in total hip replacements is aseptic
loosening which causes 75% of failures. The main culprit of aseptic loosening is increased wear
of early generation polyethylene, especially in thin and low-conformity inserts, associated with
some implant designs such as discontinuous porous-coating cementless components.
Additionally, surgical factors such as malalignment, malposition, and uncorrected instability may
contribute to aseptic loosening. [11]
It is important to note that even through there are a relatively low numbers of implant
failures, the costs can be disproportionately high. [12] The total inpatient cost of primary and
revision total hip replacement exceeds $8 billion annually, 50% of THRs recipients discharged to
inpatient care facilities for further rehabilitation, and the remainder generally have rehabilitation
services provided at home, adding another several billion dollars to the total national annual cost
of total hip replacements. [13]
Because of the past success of total joint replacement procedures, their use is expanding
into demographically different groups. Today's population most likely to receive total joint
replacements is demographically different than in the past. Compared with a few decades ago,
patients currently receiving total joint replacements are more physically active, almost 20%
heavier, live more than 25% longer, and are three times more likely to have a high school or
college education.[14] Because of the expansion of implants into younger and more active
patient groups with the expectation for longer use, osseointegration remains of critical
importance to device success.
Key to the success of these implants to the ability to osseointegrate into host bone tissues.
Osseointegration is defined as the direct structural and functional connection between living
bone and the surface of a load-bearing artificial implant. An implant is considered
4

osseointegrated when there is no progressive relative movement between the implant and the
bone with which it has direct contact. [15] This is important as micro-motion between the
implant and adjacent tissues can lead to fibrous tissue formation and implant loosening causing
implant failure. [16] The ability to osseointegrate is important to securely fixing devices in host
bone tissues to prevent these types of failure.
Implant coatings could improve patient outcomes and minimize the need for revisions of
TJRs due to septic or aseptic loosening. Bioactivity of orthopedic implants is essential for the
development of early and long-term stability of the implant in contact interfaces with the bone
tissue. [15, 17] Prosthesis-associated infections are one of the main causes of implant failure. [3]
The ability to deliver therapeutic drugs like bone growth factors and antibiotics to the implantbone interface would help alleviate these problems and improve osseointegration.
Chitosan, a cationic linear polysaccharide biopolymer derived from chitin, exhibits
properties of biocompatibility and biodegradability, as well as its bacteriostatic and drug delivery
capabilities. [18] Chitosan has been widely studied in both bone tissue engineering and
antimicrobial delivery applications as it possesses two of the most important characteristics of a
local therapeutic delivery system: biodegradability and biocompatibility. [18] When chitosan
degrades it breaks done into nontoxic products without causing any inflammatory reaction or
producing any toxic end-products when the new tissues are formed. [18]
Researchers have also examined calcium phosphate coatings for increasing bioactivity of
implants since CaP affects adhesion, proliferation, and new bone formation in osteoblasts. [19]
While CaP has shown excellent ability to support bone cell attachment, growth and
differentiation, the material is brittle, can suffer from delamination from substrates and have
exhibited higher rates of bacterial infection. [20] The opportunity to combine the bioactivity,
5

antimicrobial, and drug delivery capabilities of chitosan that with the osseointegration properties
of CaP has the potential to result in an implant coating that leads to and enhanced
osseointegration of implant devices and with the potential to prevent infections and/or delivery
therapeutics.
Research Aims
The goal of this work is to determine conditions for the manufacture of chitosan-CaP
composite coatings using electrospraying technology for potential use in enhancing
osteointegration of orthopedic implants.
Aim 1: Identify electrospray parameters for creating chitosan-CaP coatings on titanium
surfaces.
Capillary size, voltage and pressure will be adjusted to create a visibly stable aerosol
spray for depositing uniform chitosan-CaP composite coatings.
Aim 2: Determine the effects of incorporating CaP particles on the mechanical adhesive
strength of electrosprayed chitosan coatings on Ti samples.
Composite coatings will be electrosprayed from chitosan solutions containing 0, 0.25, 0.5
and 1wt% CaP nanoparticles on to silanated Ti samples. Coatings will be examined by
SEM/EDS for amount of CaP deposited in coatings and in tensile tests for effects on
coatings adhesive strengths. Coating fracture surfaces will be examined by SEM and
FTIR for adhesive-cohesive failures of the coatings.
Aim 3: Determine effects of incorporating CaP particles into electrosprayed coatings on
coating hydrophilic properties and on ability to support bone cell attachment and growth.
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Coatings will be electrosprayed from chitosan solutions containing 0, 0.25, 0.5 and 1wt%
CaP nanoparticles. Coatings will be examined using water contact angle measurements
to determine effects of CaP nanoparticle incorporation on the hydrophilic characteristics
of the coatings. The effects of CaP nanoparticle incorporation on the attachment and
growth of bone cells will be evaluated over 5 days.
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CHAPTER II
LITERATURE REVIEW
Implant materials
Implants can be constructed out of many different types for materials such as metals or
polymers. Metals utilized in orthopedic implants include surgical grade stainless steel
(commonly 316L), cobalt-chromium (Co-Cr) alloys and pure commercial titanium (Ti) or
titanium alloys.
Stainless steel is one of the most common metallic alloys used in orthopedic applications.
Type 316L cold-worked stainless steel is one of the most common types used in implant
applications. The “L” denotes that this steel is a low carbon alloy for improved corrosion
resistance and the “316” denotes that the steel is an austenitic class of stainless. Type 316L
stainless steel selected for surgical implants contains approximately 17 to 19% of chromium, for
corrosion resistance, and 14% nickel, to stabilize the austenite to stainless steel. [5, 21]
Additionally, molybdenum is added to the stainless-steel alloy that forms a protective layer
sheltering the metal from exposure to an acidic environment. [5]
Co-Cr alloys are well known for their biocompatibility due to a durable chromium oxide
surface layer and the formation of Co- Cr- and Mo- carbides provide these alloys with higher
wear resistance compared to Ti alloys.[22] Co-Cr also exhibits mechanical properties similar to
stainless steel, a result of a multiphase structure and precipitation of metal carbides, which
increase the hardness of Co-Cr alloy and gives high wear resistance. The alloy composition used
in orthopedic implants is described in industry standard ASTM-F75: cobalt with 27 to 30%
chromium, 5 to 7% molybdenum, and other important elements such as less than 1% manganese
and silicon, less than 0.75% iron, and less than 0.5% nickel. Moreover, tensile and fatigue
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strength increases radically as they are heat-treated. [23] However, Co-Cr alloys tend to have low
ductility, which can cause component fracture, and Co-Cr’s high modulus can create a mismatch
between the implant and bone which can contribute to stress shielding. Co-Cr alloys are most
commonly used to make articulating components of total joints including knee and hip joints due
to high wear-resistance and biocompatibility.[6] Co-Cr alloys tend to be corrosion resistant and
chemically inert. This minimizes the possibility of irritation, allergic reaction, and immune
response from surrounding tissues. However, despite these implants’ good corrosion resistance,
release of chromium, cobalt and nickel ions in vivo are a major concern as these metals are
known carcinogens.
The most common Titanium alloy used in total joint devices is Ti-6Al-4V since it has
sufficient mechanical strength with a modulus close to native bone. This two-phase alloy
contains 6% Al and 4% Va. (Ti 6 Al 4V). [5] These added elements act as Phase- condition
stabilizers. Aluminum is alpha-phase condition stabilizer and it also increases the strength and
decrease the weight of the alloy. Vanadium acts as beta-phase stabilizer. The alloys most
commonly used for orthopedic implants are of the alpha-beta variety. [24]
Titanium and its alloys are more corrosion resistant than Co-Cr alloys and 316L stainless
because of the formation of titanium oxide on the surface. [24] However, the surface oxide layer
is not very resistant to wear and thus is not optimal for articulating surfaces. Abrasion of the
oxide layer can lead to the release of particles into the surrounding tissues causing undesirable
tissue response such as aseptic loosening. However, because of excellent corrosion resistance,
high strength and a modulus closer to bone than stainless steel or CoCr alloys, titanium is used
where integration into bone is important like the stem of the femoral component of total hip
implant. [24]
9

Bone
Bone is the framework of the body and is responsible for a host of functions including
aiding in motion, housing the internal organs, providing structure, storing and distributing ions,
and assisting in blood cell formation. It is a composite of organic products of cellular synthesis
and mineral deposited by extracellular matrix calcification. There are two main types of bone
known as cortical and cancellous bone.
The hard, outer layer of bones is composed of cortical bone, also called compact bone as
it is much denser than cancellous bone. It forms a hard-dense layered exterior (cortex) of bones
and functions to support the whole body, protect organs, provide levers for movement, and store
and release chemical elements. [25] Cortical bone is very important for maintaining body
structure and weight bearing because of its high resistance to bending and torsion.
Typically found at the ends of long bones, near joints and in the interior of vertebrae,
cancellous bone, also called trabecular or spongy bone, is a meshwork of weaker and more
flexible spongy tissue known as trabeculae which is made of mature adult bone. It is typically
found at the core of vertebral bones in the spine and the ends of the long bones such as the femur
or thigh bone. [25]
After it is formed bone is constantly undergoing remodeling to adapt to new loads and
repair damage. The three different types of cells responsible for bone formation and remodeling
are osteoblast, osteoclast, and osteocytes. [25] Osteoblast are mononucleate bone-forming cells
derived from mesenchymal stem cell lines. The osteoblast creates and repairs new bone
depositing osteoid which mineralizes to become bone. Osteoid is the unmineralized, organic
portion of the bone matrix that forms prior to the maturation of bone tissue and is primarily
composed of Type I collagen. The collagen fibers are used as a framework for mineralization.
10

Osteoclasts are considered bone reabsorption cells and oversee the removal of bone matrix. They
secrete enzymes and hydrogen ions that acidify the local environment and breakdown the bone
matrix. There is a constant cycle of bone formation and reabsorption that is used to remodel the
bone. Lastly, most common cell type in bone osteocytes are the least metabolically active mature
bone cells. However, they are responsible for the physical attributes of bone and are important
regulators of bone mass by controlling the activity of both of osteoblasts and osteoclasts. They
play are a key endocrine regulator of phosphate metabolism and biomineralization. [25]
Osseointegration
Osseointegration is defined as direct interface of living bone tissue with surgical implants
without the formation of interpositioned connective tissue. [26] The osseointegration process
securely fixes the implant in the living bone to allow for load bearing functions. An implant is
considered osseointegrated if there is no relative motion between the implant and bone.
Osseointegration can be compared with direct fracture healing, in which the fragment ends
become united by bone, without intermediate fibrous tissue or fibrocartilage formation. [17] A
fundamental difference, however, is that osseointegration unites bone not to bone, but bone to a
foreign material, the implant.
Current standards state that an implant is considered osseointegrated when there is no
progressive relative movement between both the implant and the bone with which it has direct
contact. [26] The process of osseointegration reflects an anchorage mechanism whereby nonvital components can be reliably incorporated into living bone and which persist under all normal
conditions of loading. [17]
Following implant placement, two stages of healing need to occur for the implant to
begin osseointegration. According to Misch the two stages in osseointegration each can stage
11

split into two substages. [27] Stage one is the surface modeling where first woven bone is formed
at implant site. This bone has numerous irregular shaped osteocytes, a relatively low mineral
density characterized by random, felt-like orientation of collagen fibrils. As this woven callus
matures it is replaced by lamellar bone to achieve sufficient strength for loading.
The second stage is remodeling and maturation which begins at the same time when
woven callus is completing lamellar compaction. [17] During this stage callus starts to resorb,
and remodeling of implant interface begins. The interface remodeling helps in establishing a
viable interface between the implant and original bone. This remodeling decreases callus volume
and interface remodeling continues based on loading. [17,27]
The clinical term osseointegration describes a state that provides for long-term stability of
a prosthesis; however, this is not a biological property of any implant system or metal. In vivo
and in vitro research have also been performed to evaluate the biology of the healing response to
the implant surface and how the material's characteristics, such as surface preparations, chemical
composition, coatings and sterilization procedures may affect the short- and long-term stability
of the metallo-biological interface and achieve osseointegration. [28] One strategy to improve
osseointegration is to coat implants to provide surfaces that accelerate bone cell attachment,
growth and differentiation.
Coatings
Common biomaterials used as coatings on implants include bioactive glass, calcium
phosphates, and poly(lactic) acid (PLA). [8,19,20,29,30,31]
Bioglass has been investigated for use as coatings due to its ability for direct bonding
with host tissues. Bioglass is a silicate-based (SiO2-CaO-P2O5) bioactive glass, that when
implanted, forms a hydroxyapatite layer on the bioglass surface. This layer allows for the
12

bioglass to bond to living bone. Bioglass has the potential to bond to hard, as well as soft tissue,
depending on composition and structure. Studies have reported that coatings of bioglass on
metallic and ceramic implants improve the rate of osseointegration. [29]
Calcium phosphate (CaP) materials have also been widely investigated as coating
materials due to their chemical similarity to native bone mineral. Calcium phosphate is a family
of compounds containing calcium Ca2+ and phosphate (PO4)3-. There are many types of CaP
each with its own unique chemical, structural, mechanical and degradation properties with
hydroxyapatite (HA) being the most widely used CaP in implant coatings.[19] Due to its
chemical similarity to human bone and teeth, hydroxyapatite (HA) is the most widely used
biomaterials in implant coatings. Hydroxyapatite is a mineral of the apatite group that is the main
inorganic constituent of tooth enamel and bone. It has been shown to have excellent
biocompatibility, good osteoconduction and osseointegration. While both bioglass and CaP have
shown excellent ability to support bone cell attachment, growth and differentiation, both
materials are brittle, suffer delamination from the titanium substrate and have exhibited higher
rates of bacterial infection which have limited their use clinically. [20] Thus, there is a need to
modify these materials or search for other new biomaterials to circumvent these drawbacks. [30]
PLA has also been investigated for use as implant coatings. PLA is the polymeric form of
lactic acid and is the natural product of fermentation of sugars in sugarcane and corn by
microorganisms. [32] It is a biodegradable thermoplastic with good mechanical strength and
excellent biocompatibility. PLA-based materials are extensively used as biomedical materials in
the fields of controlled drug delivery systems and tissue regeneration. These materials have also
been used as alternatives for ceramic based polymeric materials in order to reduce impact on
environment. [8] In composite scaffolds, PLA has been shown to speed up the degradation of
13

other materials causing faster overall degradation. Some disadvantages of PLA include excessive
brittleness and slow crystallization; leading it to often be copolymerized with hydroxyalkanoic
acid (a biodegradable thermoplastic), or blended with other polymers, fillers (include talc, mica,
kaolin, starch and more), or plasticizers.[31]
Past research efforts have been dedicated to developing a suitable implant coating
materials that would improve osseointegration and have the potential to locally deliver drugs to
stimulate bone formation and/or to inhibit or prevent bacterial attachment/biofilm formation on
implant surfaces. Chitosan, a naturally derived polysaccharide, has piqued the interest of
researchers as an implant coating due to its biocompatibility, biodegradability, osteoconductivity,
bioadhesivity, bacteriostatic and drug delivery capabilities. [33]
Chitosan
Chitosan is a cationic, linear polysaccharide made of randomly distributed β-(1→4)linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit) derived
from chitin, an abundant biopolymer in insect and crustacean exoskeletons. Chitin is widely
distributed in nature and serves as an inexpensive readily available resource. [18] Chitosan has
been widely studied in both bone tissue engineering and antimicrobial delivery applications as it
possesses two of the most important characteristics of a local therapeutic delivery system:
biodegradability and biocompatibility. [18] When chitosan degrades it breaks done into nontoxic
products usually oligomeric units without causing any inflammatory reaction or producing any
toxic end-products when the new tissues are formed. [18]
The two most commonly cited factors for determining the properties of chitosan are its
degree of deacetylation (DDA) and molecular weight (MW). Chitosan DDA has often been cited
as an important parameter that determines many physiochemical and biological properties of
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chitosan like cell response, crystallinity, degradation, and hydrophilicity. Chitosan with 50%
DDA has the most rapid degradation rate; whereas, 0% DDA chitin and 100% DDA chitosan
exhibit the slowest degradation rates. [34] These differences can be explained by the crystallinity
of the polymers as chitosan’s with the greater the percentage of DDA are more crystalline the
chitosan. Highly crystalline polymers are more difficult to degrade compared to amorphous
polymers. Some methods to modify DDA are changing processing conditions such as the
concentration of sodium hydroxide, reaction temperature, reaction time, and number of
successive reactions. [34]
MW has been shown to be an important factor in chitosan properties such as crystallinity,
degradation, tensile strengths and moisture content. Typically, the molecular weight of
commercially produced chitosan is between 3.8 and 20 kilo-Daltons (kDa). However, chitosans
with MW as high as 710 kDa have been commonly tested in bone implants. Some studies have
reported that chitosans with high MW’s, usually 600-1000 kDa, have a significantly higher
tensile strength and moisture adsorption when compared to chitosans with similar DDA’s but
lower MW’s, 50–60 kDa. [35]
Because of the versatility that chitosan provides it has been developed into many
different technologies that take advantage of these properties and utilize them. Some examples
include hydrogels, nanoparticles, paste, tissue scaffolds, and sponges. [36] Coatings and thin
films have been investigated in order to tune the surface properties of various medical devices.
[37]
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Surface Coating Methods
There are variety of techniques used to coat implant metals and ceramics with chitosan.
Some methods include plasma spraying, sputter coating, solution casting and spin coating and
electrostatic methods are layer-by-layer, electrolytic and electrophoretic deposition.
Plasma Spray coating is a technique were the spraying of molten or heat softened
material onto a surface provides a coating. Material in the form of powder is injected into a very
high temperature plasma flame, where it is rapidly heated and accelerated to a high velocity. The
hot material impacts on the substrate surface and rapidly cools forming a coating. The spray
greatly increases the surface area of implants by increasing surface roughness. The plasma
spraying coating technique has been successfully used to adhere HA to commercial titanium
implants. [38] It provides porous implant surfaces greater bone contact and can be used to coat 3
dimensional objects. However, one of the disadvantages of plasma spraying is the high
fabrication temperature as it may decompose and alter the structures organic materials, like
chitosan.
Sputter coating is a physical vapor deposition process used to apply a very thin,
functional coating on a substrate. The process starts by electrically charging a sputtering cathode
which in turn forms a plasma causing material to be ejected from the target surface. The stable
plasma created provides a more uniform deposition making coatings more consistent and durable
as the material is now a permanent part of the substrate rather than an applied coating or plating
of the surface. Like plasma spray, the high energy nature of this method is not conducive to
coating chitosan.
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Spin coating rotates the substrate deposited with chitosan solution at a constant angular
velocity. The centripetal force will spread the chitosan uniformly on the substrate and excessive
solution will be thrown off.
Solution casting involves casting chitosan solution on the substrate surface and allowing
the solvent to dry under room temperature or in a heated environment. The thickness of the
coating can be controlled by using carrier tape or doctor blade to spread or cast the chitosan
solution in certain thickness, which is not conducive to create even coating. Bumgardner et al
used solution casting to coat implant materials with chitosan and the first to use silane linkers to
improve adhesion of the coatings to the implant surfaces. [39] Using silane covalent linking
strategy, they bonded the chitosan to the surfaces of flat titanium coupons and thin (2 mm
diameter) titanium rods [39,40] They showed that the silane bonding resulted in a significant 3fold increase in coatings bonding strengths of the chitosan as compared to the simple solution
cast method without silane bonding. [39] The coatings used a high DDA chitosan that showed
low degradation and remained adhered to substrates over 12 weeks in vitro. [40] Their studies
also showed that the coatings supported bone cell attachment and growth in vitro and
osseointegrated similar to traditional CaP sputter coated Ti pins. [40] It was noted that while the
silane bonding mechanism increased coating adhesion, the bond strengths were much lower than
those for clinically used CaP coatings. To overcome that issue and to improve coating adhesion
strength, Martin et al modified Ti surfaces using surface hydroxylation methods and an organic
solvent system to enhance the deposition of the silane linker molecules to enhance bonding
strengths. [41] Their results showed that they were able to increase bond strength to be on par
with that of the CaP coatings. Several studies have used modified coating strategies to create
chitosan coatings incorporating antibiotics or growth factors for local delivery. [42,43] Studies
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incorporating antibiotics in the chitosan coatings showed that the coatings provide short term (<1
week) delivery of antibiotics at levels that were inhibitory to both orthopedic and dental
pathogens, were not cytotoxic to cultured cells and that the coatings remained attached to
implant material surfaces in mock surgical screw insertion tests. [43] Leedy et al incorporated
VEGF, a growth factor important to both angiogenesis and osteoblast differentiation, into the
chitosan coatings using an adsorption process to avoid loss of expensive growth factor during
solution casting. [44] While their results showed that the coatings released VEGF from the
coatings over 3 days, this short rapid release did not have any effect on terminal mineralization
of the bone cells on the chitosan coated specimen. However, the chitosan coatings, both with and
without VEGF, did support enhanced mineralization of the cells as compared to uncoated Ti
providing indicating potential of chitosan coatings to enhance bone healing and osseointegration
processes. [44]
While these studies demonstrate the potential of solution cast chitosan coatings for
promoting osseiontegration and for local delivery of drugs like antibiotics, there remain
significant shortcomings to this method of coating. These passive methods are difficult to
uniformly coat 3D object with irregular contour, difficult to control the thickness of the coating
and the excessive chitosan solution used is not recoverable. Furthermore, if other bioactive
compound like growth factors or antibiotics are included, the large amount of volume loss to
drying can lead to waste. Although carrier tape or medical tape can be used to control the
thickness and uniformity of coating, this method is effective on 2D plain surfaces but not 3D
surfaces with complex contours. [45]
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Another way of coating 3D objects with complex contours are with electrostatic methods
by utilizing electric charge to make layer-by-layer coats on the substrate by joining alternating
layers of polycation and polyanion using electrostatic interaction.
Electrolytic deposition passes electrical current through chitosan solution between anode
and cathode where the substrate acts as cathode. Due to the chitosan molecule’s positive charge
nature, it will be attracted towards the cathode/substrate and precipitate on the cathode/substrate
surface forming a layer of coating. However, electrophorectic deposition technique deposits
electrically charged particles suspended in liquid medium onto a substrate using external electric
field. There are several studies that have used electrolytic methods to create different composite
chitosan on many different substrates. Some of the most common materials used for these
electrophorectic deposition chitosan composites are made using bioglass or hydroxyapatite.
[46,47] Many other materials have also been paired with chitosan including graphene-related
materials, and carbon nanotubes.[48, 49] A variety of nanoparticles such as TiO2, ZnO, Fe2O3,
Cu, Ag, nano-clays, and halloysite nanotubes have been used in combination with chitosan to
develop functional composite coatings.[50] However, electrophorectic deposition of composite
coatings is challenging due to the differences in electrophoretic mobility of the two (or more)
constituents involved.
Although electrostatic methods are better at coating 3D surfaces with complex contour
when compared to passive methods like solution casting, they still are associated with several
disadvantages. Firstly, it is difficult to control the thickness of the coating due to the decrease in
chitosan concentration over time as more chitosan gets precipitated, meaning it will require
precise and accurate timing to achieve the desired thickness of coating. Secondly, the coating
process requires precise voltage control to achieve optimum coating morphology or high voltage
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will induce surface crack. Post processing on the coating may be required to get thin and uniform
surfaces. Furthermore, the process will generate excessive wastage of chitosan and any
therapeutics that are being incorporated since some of the coating solution is not recoverable.
[51]
Electrospraying
In order to overcome the drawbacks in other chitosan coating techniques, electrospray
deposition has been investigated as a method to apply coatings. Also known as
electrohydrodynamic atomization, electrospraying utilizes the principle of particle/droplet
charging to produce coating. The advantages of electrospray are: easy to coat 3D surfaces with
complex and irregular contour by utilizing electric charge, precise control on coating thickness,
capable of controlling the size distribution of the sprayed droplets, resulting in less waste of
coating material as compared to solution casting and other electrophoretic deposition methods.
[52] Furthermore, electrospraying has been shown to allow for the easy to incorporation of
therapeutic molecules or other components into coatings. Studies have investigated the
application of electrospray deposition method to create chitosan-based coatings on implant
materials to improve the osseointegration and the local delivery of bioactive materials such as
growth proteins and therapeutics. [53,54]
In electrospraying chitosan, the chitosan solution is pushed out from the nozzle by the
applied pressure from the syringe pump. The nozzle is connected to positive high voltage source
to charge the chitosan solution as well as creating a high electric field between the nozzle and
substrate. As the chitosan droplet emerges from the nozzle, the electric field applied will deform
the interface of the droplet [52]. The electric charge generates electrostatic repulsion force within
the droplet. The maximum amount of electric charge a droplet or particle could carry is called
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Rayleigh limit. If the number of charge in a droplet exceeds its Rayleigh limit, electrostatic
repulsion force overcomes the surface tension of the droplet, the excess charge will be dissipated
through the breakup of large droplet into micro to nano-sized droplets. Since the micro/nano
sized droplets carry similar charge, the Coulomb repulsion between the droplets will disperse and
not reaccumulate together. The electric field between the nozzle and substrate drives the
micro/nano sized droplets towards the substrate.
Chng et al used electrospraying to create chitosan coatings on Ti materials. [52] Their
study examined the potential to bond electrosprayed chitosan coatings to surfaces of titanium via
silane linker molecules. Their results demonstrated that the electrosprayed coatings were well
retained during simulated implantation into sawbone materials as compared to non-bonded
electrosprayed coatings. While this work demonstrated that electrosprayed chitosan could be
covalently bonded to surfaces of titanium via silane linker molecules, the compatibility of the
coatings was not evaluated.
This work will further evaluate the silane bonded electrosprayed chitosan coatings and to
examine the impact of incorporating CaP particles into the coatings. Calcium phosphate (CaP) is
a major component of bone and have been widely used bone substitutes in bone tissue
engineering. When used as implant coating, CaP has been shown to improve osteointegration of
implants into the bone tissues. CaP nanoparticles have been studied due to their high bioactivity,
biocompatibility, chemical stability and strong adsorption ability under physiological conditions.
[55] Some of these properties can be further tailored through both surface modification and
structural design to achieve a sustained, controlled, or targeted release of a therapeutic. By
incorporating CaP nanoparticles into a chitosan coating, it may be possible to improve both
implant integration and deliver therapeutics such as antimicrobials to prevent bacterial infection.
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The focus of this work will be on the ability to create chitosan-CaP composite coatings using
electrospray methodology and evaluate coating properties and initial in vitro compatibility.
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CHAPTER III
Electrosprayed Chitosan -Calcium Phosphate Nanoshell Composite Coatings on Silanated
Titanium Plates.
Abstract
The aim of this work was to take advantage of the electrospray technology and the
osteocompatibility of both chitosan and calcium phosphate (CaP) to fabricate chitosan coatings
loaded with CaP nanoshell particles. The key electrospray parameters of capillary diameter,
voltage, and pressure were identified and adjusted for creating uniform chitosan-CaP coatings on
titanium surfaces. Coatings containing from 0 to 1 wt% CaP particles to chitosan mass were
electrosprayed on to silanated titanium to create composite coatings bonded to the metal surface.
Scanning electron microscope (SEM) and energy dispersive X-ray spectroscopy (EDS) showed
that CaP particles were homogenously distributed throughout the chitosan coating. Mechanical
tensile testing demonstrated that there was no statistically significant loss of coating adhesion
strength in coating up to 1.0 wt% CaP. Furthermore, the incorporation of CaP was shown to
support growth of bone cells on the coating. We have demonstrated that CaP can successfully be
incorporated into electrosprayed chitosan coating.
Introduction
Arthritis is the leading cause of disability in the U.S. and, according to the Center of
Disease Control (CDC), between 2013–2015, an estimated 54.4 million US adults (22.7%) and
300,000 juveniles have been diagnosed with arthritis.[1,2,56] In patients with severe arthritis,
ongoing pain, limited function, and diminished life quality, biomedical total joint implant
devices have become a reliable and effective means for replacing and restoring joint function. In
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2014 there were 370,770 total hip replacements and 680,150 total knee replacements in elderly
or children. [4,13,14]
While most of these orthopedic implants perform well during their operational lifetimes,
reports indicate about 5% of implants experience some type of failure. [1, 57, 58] Common
causes of failure include mechanical loosening, infection, and dislocation. [9] Early fixation of
implants in bone has been identified as a critical step in obtaining long-term success of total hip
replacement. [59] Titanium is widely used as components of orthopedic implant devices due to
its capacity for osseointegration, as well as its excellent corrosion resistance and high fatigue
limit.[5] To further improve osseointegration of titanium implants, surface coatings using
different materials including calcium-phosphates, bioglass, and polymers such as chitosan have
been explored. [20, 29, 31, 55, 60]
Calcium phosphate (CaP) is a highly biocompatible inorganic biomaterial. CaP coatings
have been extensively investigated as implant coatings due to their similarity to native calciumphosphate mineral found in bone. [19, 20, 55, 60] CaP coatings have demonstrated excellent
biocompatibility, osteoconduction, and osseointegration, but are observed to be brittle, suffer
delamination problems, and can exhibit higher rates of bacterial infection compared to non-CaP
coated implants, limiting their use clinically. [20, 30] In addition, calcium-phosphate coatings
made by traditional sputter coating, plasma spraying, or other high energy coating methods limit
ability to incorporate of bioactive agents including antimicrobial and growth factors. [19, 60]
Bioglass has also been used as a coating. Bioglass is a silicate-based (SiO2-CaO-P2O5)
bioactive glass, that when implanted, forms a hydroxyapatite layer on the bioglass surface. [29]
Studies have reported that coatings of bioglass on metallic and ceramic implants improve the rate
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of osseointegration. [29] However, due to bioglass’s brittleness and relatively poor mechanical
properties, clinical applications have been limited to non-load bearing implants. [61]
Natural polymers have been used in medical applications for decades thanks to their
biocompatibility, biodegradability, and tunable properties. Chitosan, a linear polysaccharide
derived from the deacetylation of chitin polymer, has attracted interest as an implant coating
material due to its biocompatibility and biodegradability, as well as its bacteriostatic and drug
delivery capability.[18, 34, 35, 39, 51] Many techniques have been used to fabricate chitosan
coatings including solution casting with silane bonding, sputter coating, freeze-drying, layer-bylayer electrolytic deposition, and electrospraying. [37, 39, 41, 51, 52] These coating methods
have been reported to create chitosan coatings that are able to support bone cell attachment,
growth and differentiation, osseointegrate in animal models and or ability to incorporate and
release bioactive agents to stimulate bone healing and or prevent microbial complications in vitro
and or in vivo models. However, each method has its drawbacks. In solution casting it is difficult
to coat complex shapes uniformly. High energy coating methods like sputter coating can
damage/limit incorporation of expensive therapeutics. Layer-by-layer electrolytic deposition can
require large volumes of coating solution as the entire substrate must be submerged in solution.
Electrospraying is a method, based on the principle of particle/droplet charging, that
overcomes many of the limitations of other chitosan coating fabrication methods. The
advantages of electrospray are: easy to coat 3D surfaces with complex and irregular contour by
utilizing electric charge, precise control on coating thickness, capable of controlling the size
distribution of the sprayed droplets and process results does in less waste of coating material as
compared to solution casting and other electrophoretic deposition methods. [52]
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Furthermore, electrospraying is not damaging to therapeutic molecules and makes it easy
to incorporate therapeutic molecules or other components into coatings. Several studies have
investigated the application of electrospray deposition method to create chitosan-based coatings
on implant materials to improve the osseointegration and the local delivery of bioactive materials
such as drugs for drug delivery application with. [52, 53, 54]
The aim of this work is to take advantage of the electrospray technology and the
osteocompatibility of both chitosan and calcium phosphate mineral to fabricate chitosan coatings
loaded with CaP nanoparticles. The key electrospray parameters of capillary diameter, voltage,
and pressure were identified and adjusted for creating chitosan-CaP composite coatings on
titanium surfaces. Composite coatings were then evaluated and compared to plain chitosan
coated and uncoated titanium controls for changes in hydrophobic/hydrophilic properties,
coating adhesive strengths, and ability to support bone cell attachment and growth. Composite
coatings were also evaluated for distribution of CaP particles within the electrosprayed coatings.
Materials
Titanium (Titanium Industries, commercially pure ASTM F67 grade 2, Hillsboro, TX)
was used as substrates for fabricating electrosprayed coatings Tri-ethoxy- silylbutyraldhyde
(TESBA) silane, purchased from Gelest (product code: SIT8185.3, Morrisville, PA), was used
for the silanation of the titanium substrates. Carbon nanospheres were obtained from the Physics
Department of the University of Memphis. Chitosan powder (92.6 DDA, molecular weight 300700kDA) purchased from Heppe Medical Chitosan GmbH, Germany, product no.: 24711, was
used for making the chitosan coatings. All other reagents and chemicals used were obtained from
Thermo Fisher Scientific, USA.
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Methodology
Sample Preparation
Cleaning and Hydroxylation of Titanium Substrate
Titanium substrates were wet ground with a sequence of 400, 600, 800, and 1200 grit
silicon carbide grinding paper and then cleaned with dilute soap and warm water. Next, the
substrates were ultrasonically (FS60H, Thermo Fisher Scientific, Waltham, MA) cleaned with
acetone, 100% ethanol, and de-ionized water for 10 min each. After cleaning, samples were
submerged in 5M sodium hydroxide (NaOH) at 60oC for 24 h to enhance surface hydroxide
formation.[41] Samples were washed in fresh deionized distilled water (DI) water and stored in
DI Water to prevent drying until silanation step. [41]
Silanation of Titanium Substrate
The silanation process of the titanium substrate was adopted from Chng et al (2019). [52]
First, titanium substrates were placed in a glass pyrex dish on a magnetic stir plate and stirred in
a 5:95 (v/v) de-ionized water/ethanol solution (pH = 4.5). The solution pH was maintained to
4.5 using pH meter (Accumet BASIC, AB15 pH meter, Thermo Fisher Scientific) and 1M acetic
acid and 1M sodium hydroxide solution. [52] Tri-ethoxy- silylbutyraldhyde (TESBA) silane was
added to make a 2 % (v/v) solution of silane in ethanol solution. The titanium substrates were
placed on a belly dancer (IBI Scientific, The Belly Dancer, Thermo Fisher Scientific, Waltham,
MA) for 10 mins to react with silane which the ethoxy groups of the silane molecules are
organized via H-bonding with the hydroxide group on the titanium substrate surface. [52] The
silanated substrates were then rinsed with ethanol to remove non-adhered silane and cured at 110
°C in oven (Thermo Fisher Scientific, Waltham, MA) for 10 mins to convert the H-bond between
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silane and titanium to covalent Si-O-Ti bonds. The silanated substrates were immediately stored
in a vacuum chamber after being cured in the oven. [52]
Chitosan Solution Preparation
For electrospraying 3 parts of a 1 wt% chitosan in 0.5v% acetic acid solution was mixed
with 1 part of a 95v% ethanol 5v % 2-propanol solution. The alcohol solution is used to reduce
the viscosity and surface tension of the chitosan solution to make it sprayable [52]. The solution
was stirred using a magnetic stirrer to ensure thorough mixing. After mixing, the pH of the
solution was adjusted to 5.1 and then sonicated for 7 minutes (Sonic probe, CL-18, Thermo
Fisher Scientific, Waltham, MA) to remove microbubble in the solution before being
sprayed.[52]
Synthesis of CaP Nanoshells
The procedure for the synthesis of the CaP nanoshells was adapted from Wu et al. [62]
Briefly, CaP nanoshells were prepared via calcium phosphate condensation reaction around
carbon nanosphere precursors. Sodium chloride (NaCl) was added to a volume of DI water and
stirred for 15 minutes, followed by potassium chloride (KCl), Carbon Nanospheres, calcium
chloride dihydrate (CaCl2 · 2H2O), magnesium chloride hexahydrate (MgCl2 · 6H2O),
disodium phosphate (Na2HPO4), sodium bicarbonate (NaHCO3) are added sequentially at 10minute intervals and continuously stirred using a magnetic stir plate (Isotemp, Fisher Scientific).
Immediately, 20 % of the final volume of DI water was added to the solution. The pH was
adjusted using tris(hydroxymethyl)aminomethane base and hydrogen chloride solutions to 7.4.
The solution was stirred about 15 minutes, and then remaining DI water was added to bring the
final volume (1000 ml). The entire solution is placed in an oven at 37 oC for 3-4 days for
particles to settle out. The precipitate was washed until the product turned into light grey.
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Finally, the product was dried and ground (Cole-Parmer Mortar and Pestle) and baked in oven at
280oC for 5 h to remove the carbon nanosphere precursors from the final CaP shells. [62] The
obtained CaP Nanoshells were stored in an airtight container until further use.
Incorporation of CaP shells into chitosan solution
Calcium phosphate shells were incorporated into the chitosan electrospraying solution at
0.25, 0.5, 1.0 wt% of CaP shells to wt% chitosan powder. Solutions were ultrasonicated (Sonic
probe, CL-18, Thermo Fisher Scientific, Waltham, MA) for 5 minutes using an ultrasonic probe
to break apart any CaP aggregates in solution and then vortexed to ensure homogenous mixing of
CaP shells in the solution prior to spraying.
Electrospraying Parameters
The initial spray parameters used were based on those previously developed using the
same in-house custom electrospray set up. [52] These parameters were subsequently modified to
achieve spray flowrate, spray stability, and spray conditions of the chitosan - CaP shell solution
to achieve a stable uniform coating on the titanium surfaces. The spray flow rate refers to the rate
of volume of the chitosan solution that can be ejected from the electrospray and spray conditions
refer to dry or wet deposition of the chitosan droplets on the substrate. The spray stability refers
to the ability of the electrospray to sustain the stability of the spray without interruption such as
large droplet formation or accumulation of spray solution on the nozzle. The spray parameters
were adjusted by trial and error based on original conditions established for spraying chitosan
developed by Chng et al (2019).[52] After being sprayed, coatings were neutralized in a 0.25 M
phosphate buffer solution then rinsed with DI water and dried at room temperature in a laminar
flow hood.
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Characterization
Particle size and charge determination
The particle size distribution of CaP nanoshells was measured using dynamic light
scattering (Nano-ZS, Malvern Instruments, UK). From the measured distributions, Z-average
diameters of the nanoshells were calculated. A micro-electrophoresis device (Nano-ZS, Malvern
Instruments, UK) was used to determine the surface charge of the CaP nanoshells and acquire
zeta-potential. For both the measurements, the samples were diluted with deionized water to
avoid or reduce the multiple scattering effects.
Electrospraying parameter determination
The initial starting parameters for electrospraying chitosan can be seen in Table 1. The
parameters were adjusted one by one to determine what which of the variables where key for a
successful coating. Order of which parameters were adjusted were capillary size, pressure,
voltage, substrate-capillary distance.
Table 1: Original electrospraying parameters for chitosan.
Parameter
Capillary size
Capillary material
Voltage
Pressure
Substrate-Capillary distance
Base Chitosan Solution

Value
250 µm
Silica
6.3 kV
45 PSI
3 mm
3:1 (95 % DDA, 1 % wt chitosan 0.5 % acetic acid + ethanol)

Shape and Surface morphology of CaP nanoshells
To determine the surface morphology, prepared CaP nanoshells were observed using
scanning electron microscopy (SEM) (NovaNanoSEM650, FEI/ThermoFisher Scientific,
Waltham, MA, USA). [62] Briefly, the nanoshells were evenly mounted on to the metallic stub

30

and further sputter gold coated. All images were recorded at an acceleration voltage of 15-18kV.
The images were recorded with and without false color EDS overlay.
Determination of silane deposition on titanium samples
Fourier transform infrared (FTIR, Perkin Elmer Frontier, Waltham, MA) in attenuated
total reflectance (ATR) mode was used to examine the surface chemistry, bonding of silane and
chitosan to the titanium surface. The samples were examined with clean polished titanium as
background run after sodium hydroxide (NaOH) and silanation treatment.
Determination of surface morphology of chitosan coatings loaded with CaP nanoshells
To confirm and evaluate the incorporation of CaP nanoshells into the chitosan coatings,
the samples were examined using SEM and EDS. SEM was used to examine surface morphology
of the coatings with and without CaP nanoshells. Coatings were further evaluated in SEM using
EDS to map Ca and P distribution as an indicator of CaP nanoshell distribution in coatings.
Sample were also evaluated from the edge using SEM and EDS to examine CaP distribution
through the depth of the coating. Edge view was taken by cutting a piece off of an already coated
sample so it could be placed on its side in the SEM.
Determination of bond strength of the chitosan coating
To test the bond strength of the coatings to the Ti surfaces, aluminum studs were attached
to the coatings using GorillaWeld Steal Bond epoxy (Gorilla Glue, United States). [52] Glued
specimens were loaded into an Instron 33R test frame (Series 4465, Instron, United States) using
custom fixtures and tested in tension using 5 kN load cell at 0.5 mm/min until failure. The
maximum tensile stress before failure was recorded. The test specimens were examined visually
to determine the failure mode either adhesive failure of the glue, or cohesive failure of the
coating. The test groups were control groups of electrosprayed coatings on silanated and non-

31

silanated Ti, and electrosprayed coatings with 0.25, 0.5, 1.0 wt % CaP on silanated Ti. The 95%
confidence intervals and ANOVA with post-hoc testing using Holm-Sidak method for statistical
comparison. All groups were compared to each other.
Determination of hydrophilic nature on chitosan coating
To assess the change in hydrophilic or hydrophobic properties of the chitosan coating
after incorporation of CaP nanoshells water contact angle measurements were performed using
Contact Angle Measurement (CAM) (VCA Optima, AST Products, INC, Billerica, MA, USA).
The samples examined were cleaned and polished non-silanated titanium (control) and
electrosprayed chitosan coatings with 0.0, 0.25, 0.5, and 1.0 wt % CaP on silanated titanium
respectively. The droplet size used for testing the nature of coatings was 3 μL for all the samples.
Four replicate (n=4) samples per test group were evaluated. The 95% confidence intervals of the
angles were calculated for statistical comparison.
In-vitro cytocompatibility studies of the chitosan coatings
A cytocompatibility study was performed on the chitosan coatings using W-20-17, ((W20 clone 17] (ATCC® CRL-2623™)), preosteoblast mouse bone marrow stromal cells. The cells
were first cultured in Dulbecco's modified Eagle's medium (DMEM), with 10% fetal bovine
serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin at 37 °C in a 5 % CO2 incubator.
Cells were seeded on the Ti control and test chitosan-CaP coated specimen (9.5 mm diameter
disks) in 48 well plates at 3x104 cells/well in 0.5 ml of medium and allowed to attach overnight.
Medium was removed and replaced with fresh medium every 2-3 days over the experimental
time frame. Viability was measured after 1, 3, and 5 days after seeding. Viability of the cells was
determined using the Cell Titer glo assay (CellTiter-Glo® Luminescent Cell Viability Assay,
Cat.# G7570, Promega). The Cell Titer glo assay is a homogeneous method of determining the
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number of viable cells in culture based on quantitation of the ATP present. Results were
normalized to tissue culture plastic control. There were three replicates per group for each time
point. Data was then analyzed statistically using two-factor ANOVA with replication. Due to
interactions data were analyzed separately based on days.
Cells on a single sample from each test group were stained using Alexa Fluor and
methylene blue for qualitative imaging of cell attachment and spreading. After 1 day or 3 or 5
days, one sample was removed, rinsed with PBS and fixed with 1.5 % glutaraldehyde followed
by washing with PBS and rinse with 0.5 % Triton X buffer. Samples were stained in imaged on
microscope.
Results
Optimization of Electrospraying Parameters
The initial starting parameters for electrospraying chitosan can be seen in Table 1.
In initial trials a 250 µm capillary tube was used for electrospraying. However, the
solutions with as little as 0.25 wt% CaP particles showed formation of aggregates inside the
capillary tube. (Figure 2) These aggregates were formed by CaP particles building up on the
walls of the capillary tubes. The accumulation of the aggregates caused clogging of the tubes and
lead to incomplete coatings (Figure 3). To overcome this issue, the capillary size was increased
to the next size up, 320 µm inner diameter. Aggregates were not observed to form in capillary
tubes with 320 µm with 1wt% CaP particles and complete coatings were able to be made on test
substrates.
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Figure 2. A 250 µm capillary tube with CaP arrows indicating aggregate clogs.

Figure 3. Titanium sample that had coating process stopped due to capillary clogging mid-spray.
Arrow A indicates where coating is, arrow B indicates where coating is not.
With the increased diameter of the capillary tube the initial pressure of 45 PSI was found
to be too high and pushed too much material out of the capillary leading to loss of spray cone.
This resulted in coatings being oversaturation (Figure 4). The pressure was gradually reduced to
15 PSI, for the 320 µm capillary tubes at which a stable spray cone was visually observed.
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Pressure was further reduced to 13 PSI to prevent flooding of the substrate during longer
coatings.

Figure 4. Titanium sample that had coating process halted after oversaturation (flooding) with
chitosan.
Changing the substrate-capillary distance and voltage of the electrospraying apparatus
proved to hold no visually discernible improvements on coating quality versus the initial
parameters. The distances between 2-7 mm were adjusted and voltages between 4-8 kV were
also tried to determine if there were improvements in coating quality. Changes in these factors in
the ranges evaluated resulted in no improvements in coating quality. Figure 5 shows the
successful results of the adjusted electrospray parameters. The revised parameters for the
chitosan-CaP solutions are shown in Table 2.
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Figure 5. Successful Chitosan CaP Coating
Table 2. Revised electrospraying parameters for chitosan loaded with CaP nanoshells.
Parameter
Value
Capillary size
320 µm
Capillary material
Silica
Voltage
6. 3 kV
Pressure
11-15 PSI
Substrate-Capillary distance
3 mm
Base Chitosan Solution
3:1 (95 % DDA, 1 % wt chitosan 0.5 % acetic acid + ethanol)
Particle size, charge determination and surface morphology of CaP nanoshells
Figure 6 is an SEM image of CaP particles made using the Wu process. [62] The particles
were observed to be spherical in shape. DLS analyses indicated that the CAP particles were in
range from 1.1-2 µm in diameter. The surface charge of the CaP shells was determined to be
26.28 mV. The electrophoretic mobility for the CaP shells was recorded as 2.34 E-04 cm2/Vs.
Results are shown in Table 3. The CaP nanoshells were spherical in shape with rough surfaces
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when examined by SEM (Figure 6). The EDS overlay image in Figure 7 showed the primary
elements present on the surface of the CaP shells. The most abundant elements observed were
Sodium, Phosphorous, Oxygen and Calcium. The lack of carbon in present in the shells indicates
that the carbon precursors have been removed.
Table 3. ZETA Potential Results
DLS

Surface Charge

Electrophoretic Mobility

1.1-2 um

26.28 mV

2.34 E-4 cm2/Vs

Figure 6.SEM of Calcium Phosphate nanoshells
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Figure 7. SEM with EDS overlay of Calcium Phosphate nanoshells surface
Determination of silane deposition on titanium samples
The result of FTIR analysis of the the silane deposition on the titanium samples is
depicted in Figure 8. In the figure, spectra 1 is the FTIR of the cleaned titanium. Spectra 2 is the
FTIR after the NaOH treatement of the Ti sample, there is a noticable increase in the broad peak
between 3100 and 3600 cm-1 indicative of an increase in the prescence of -OH groups on the
surface of the material. Spectra 3 corresponds to silanated titanium with peaks from the TESBA
molecule at 1050 cm-1 and 1150 cm-1 corresponding to -Si-O bonds and peaks at 1700 cm-1
corresponding to -C=O bonds.
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Spectra 1
Spectra 2

Spectra 3

Figure 8. Prediction of surface chemistry and bonding of silane and chitosan to titanium using
FTIR spectra. Spectra 1 corresponds to a cleaned titanium. Spectra 2 corresponds to titanium that
has undergone NaOH treatment. Spectra 3 corresponds to silanated titanium.
Determination of surface morphology of chitosan coatings
Figures 9 are SEM images of each of the test composite coatings and the control chitosan
coatings. As compared to the control chitosan coating, all CaP coatings showed more rough
textured coatings. Qualitatively, CaP increased from 0.25 to 1wt%, the texture/roughness of the
coatings increased reflecting the increase in CaP particle content.
Figure 10 shows EDS mapping of Ca and P for identifying presence of CaP particles in
the coatings. In the image SEM with false-color, EDS overlay of chitosan, carbon of chitosan
shown in pink, coating surface on titanium loaded with CaP particles, shown in green due to the
yellow calcium and blue phosphorous color combination. With the EDS CaP particles can be
seen inside of the chitosan coating.
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Figure 9. Surface morphology recorded using SEM of electrosprayed chitosan coatings having
(A) no added CaP shells, (B) 0.25 wt % CaP shells, (C) 0.5 wt% CaP shells, and (D) 1.0 wt%
CaP
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Figure 10. SEM with false-color, EDS overlay of chitosan (pink) coating surface on titanium
loaded with CaP particle (green). Carbon-pink, green-oxygen, yellow-calcium and bluephosphorous. (A) 0.25 wt % CaP shells, (B) 0.5 wt% CaP shells, and (C) 1.0 wt% CaP
Figure 11 is a SEM image with a false-color, EDS overlay of cross-section of Ti (green)
with chitosan coating (blue and red) loaded with CaP particle (yellow and pink). This image is
the interface between the chitosan coating to the titanium substrate were the bottom of chitosan
coating can be seen. In Figure 12 the EDS of cross-section is separated into its respective
components for better observation of the titanium (green) with chitosan coating (blue and red)
with incorporated CaP particle (yellow and pink).
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Figure 11. SEM with false-color, deep-scanned EDS overlay of cross-section of Ti (green) with
chitosan coating (blue and red) with incorporated CaP particle (yellow and pink)

42

Figure 12. EDS of the cross-section is separated into respective components. (A) Cross-section
of Titanium (green). (B, C) Carbon and oxygen of the chitosan coating (blue and red). (D, E)
Phosphorus and calcium of incorporated CaP particle (pink and yellow). (F) Silicon from
TESBA on titanium.
Determination of bond strength of the chitosan coating
Results of tensile testing are in Figure 13, and Table 4. Results showed that all the
silanated groups exhibited significantly greater tensile bond strengths than the no-silanated
group. Using ANOVA and Holm-Sidak post-hoc to compare the samples with CaP to controls
showed that all groups were statistically significant from the non-silanated controls with p-values
less than 0.05 (Table 5). There was no statistically significant difference between 0.25 wt % CaP
,0.5 wt % CaP, 1.0 wt% CaP and control chitosan coatings.
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Table 4. Tensile bond strength (MPa) of silanated electrosprayed coatings with and without
Calcium Phosphate nanoshells.
Samples

Average ± standard deviation

95% CI

Electosprayed Silanated (n=12)

5.62 ± 1.70

4.66 to 6.59

Electosprayed Non-silanated (n=16)

2.51 ± 0.96

2.04 to 2.98

Electosprayed Silanated + 0.25 wt% CaP (n=6)

5.49 ± 1.34

4.42 to 6.56

Electosprayed Silanated + 0.5 wt% CaP (n=6)

4.97 ± 0.92

4.23 to 5.71

Electosprayed Silanated + 1.0 wt% CaP (n=5)

4.31 ± 0.68

3.71 to 4.91

8.00

Tensile Bond Strength (MPa)

7.00
5.62

6.00
5.00

5.49

4.97

a

a

4.31

a
4.00

a
2.51

3.00
2.00

b

1.00

0.00
Electrosprayed, Electrosprayed, CaP 0.25 wt%, CaP 0.5 wt%, CaP 1.0 wt%,
Silanated
Non-silanated Electrosprayed, Electrosprayed, Electrosprayed,
(n=12)
(n=16)
Silanated (n=6) Silanated (n=6) Silanated (n=5)
Figure 13. Results of tensile bond strength (MPa) of silanated electrosprayed coatings with and
without Calcium Phosphate nanoshells. Error bars correspond to standard deviation. Letters
correspond to groups with no statistically significant differences.
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Figure 14. Coating post tensile test failure. (A) electrosprayed, silanated, no CaP loaded ; (B)
electrosprayed, non- silanated, no loaded CaP; (C) electrosprayed, silanated, 0.25 wt% CaP
loaded; (D) electrosprayed, silanated, 0.5 wt% CaP loaded; and (E) electrosprayed, silanated, 1.0
wt% CaP loaded.
Images for the pin and fractured coatings for the different test chitosan groups is shown
in Figure 14. In Figure 14A electrosprayed, silanated coatings remained mostly attached to the
Ti substrate, only coming of the titanium in a few small pieces. The electrosprayed, nonsilanated coatings, as seen in Figure 14B showed complete removal of the chitosan coating from
the titanium substrate. Figure 14C-E shows the post-failure image of silanated, coatings
incorporated with CaP. These coatings did not peel off completely but started to rip off in
sections in which some sections of the coatings remained adhered to the Ti surface and other
parts were removed from surface. As the CaP loading percentage was increased, the coating
adhesiveness to the titanium substrate was weakened in larger proportions. Both Figure 14C and
14D show that most of the coating was still intact to the titanium substrate but still failed in
places, with the size of the failure area increasing as the CaP percent increases. This was more
evident from the coatings loaded with 1.0 wt% of CaP nanoshells seen in Figure 14E.
Determination of hydrophilic nature over chitosan coating
Table 6 depicts the results of the five test groups of cleaned and polished non-silanated
titanium and electrosprayed chitosan coatings with 0.0, 0.25, 0.5, and 1.0 wt% CaP on silanated
titanium with the accompanying 95% confidence intervals. It was observed that addition of CaP
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nanoshells in the chitosan coating caused an increase in the standard deviation of all coatings.
The 95% confidence intervals of all chitosan coatings with incorporated CaP do cross over the
95% confidence interval of the plain chitosan coatings. TiCH and TiCH 0.25 wt% CaP 95%
confidence intervals do not overlap with that of Ti, indicating that they are more hydrophilic than
the Ti. The 0.5 wt% CaP and 1.0 wt% CaP 95% confidence intervals do overlap with that of Ti,
indicating they are not different from Ti. Furthermore, none of the chitosan coatings are different
from each other as all their intervals overlap.
Table 5. Table indicating the average results of the contact angle coatings as well as the 95 %
confidence interval.
Water Contact Angle Measurements
Samples

Average ± standard deviation (n=4)

95% CI

Ti

75.6 ± 1.7o

74.0 to 77.3o

Ti + CH

71.6 ± 1.3o

70.3 to 72.9 o

Ti + CH + 0.25 wt% CaP

68.0 ± 4.8o

63.2 to 72.7 o

Ti + CH + 0.5 wt% CaP

74.7 ± 3.6o

71.2 to 78.2 o

Ti + CH + 1.0 wt% CaP

69.6 ± 4.6o

65.1 to 74.1 o

In-vitro evaluation of chitosan coatings
The results for the in vitro viability and growth of cells on the test chitosan coatings and
the control Ti are shown in Figure 15. Result of statistical analyses using two-factor ANOVA
indicated that there were statistically significant differences in the growth of cells on the different
test coatings (p=4 E-30), significant differences over time (p= 8 E-9), and there was a significant
interaction between the factors of test coatings and time (p= 6E-7). Due to interactions data were
analyzed separately based on days.
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When all groups were compared using pairwise SNK testing, at day 1 TiCH, TiCH + 0.5
wt% CaP, and TiCH + 0.5 wt% CaP coatings were all statistically similar. Furthermore, TCP and
TiCH + 0.5 wt% CaP coatings were statistically similar, and TiCH + 0.5 wt% CaP and TiCH +
1.0 wt% were also statistically similar. On day 3 all coatings were found to be statistically
different from each other. At day 5 the TCP control was statistically higher than the coated
samples. However, the TiCH, TiCH + 0.5 wt% CaP, and TiCH + 1.0 wt% CaP were all
statistically similar with the TiCH + 0.5 wt% CaP being different from all other coatings. All
groups showed a net increase in viable W2017 cells over the 5-day culture period. While all
coatings had positive cell growth and showed statistical difference from each other, no particular
group could be determined as superior.

Figure 15. In-vitro Cytotoxicity study on Chitosan electrosprayed Titanium implant using W2017 cells Non-normalized
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Due to the high density of cells on the test samples, it was not possible to evaluate the
spreading of the cells on the surfaces. Nevertheless, the staining did show many cells to be well
attached to test composite coatings. (Figure 16)

Figure 16. Day 1 of Coating
Discussion
From the ZETA potential results shown in Table 3, with a surface charge of 26.28 mV it
was evident that the CaP particles would be prone to aggregate formation causing moderate
instability. A zeta potential values lower than −30 mV or greater than +30 mV are considered to
have sufficient repulsive force to attain better physical colloidal stability, small zeta potential
values resulti in particle aggregation and flocculation due to the van der Waals attractive forces
act upon them which may result in physical instability. [63] This was evident during the
optimization of the electrospraying process, as the loading of CaP nanoshells in the spray
solution resulted in aggregation in the 250 µm capillary tube necessitating an increase to 350 µm
tube size up to 250 µm.
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The FTIR spectra (Figure 8) confirms the development of a -OH rich surface on the
Titanium and subsequent attachment of silane molecules The attachment of the silane is crucial
for electrospray/solution casting of chitosan to obtain good adhesion strength between the Ti and
chitosan itself. The ethoxy groups of this silane coupling agent react with Ti-OH group, and the
aldehyde group is expected to chemically react with amino group of chitosan. The cleaned Ti
coupon spectra reveal no specific peaks indicating no pre-existing chemical bonds (spectra 1).
The NaOH treatment (spectra 2) and aldehyde silanation process (spectra 3) indicates the
formation of surface bonds. Peaks in curve 2 that appear at wavenumbers 3600-3000 nm-1
(corresponding to OH stretching) and 1640-1555 nm-1 (that shows OH bending) confirm the
formation of the Ti-OH bond on the surface. Further, the absorbances of -CH2, C=O (aldehyde),
and Si-O-Si are shown by peaks at 2925-2850, 1720, and 1200-1000 nm-1, respectively in spectra
3, confirming the success of the silanation process at the Ti surface. This is compairible to what
is seen in the study preformed by Martin. [41]
Using SEM/EDS we were able to observe spherical CaP nanoshells produced using
calcium phosphate condensation. In the Figures 9 and 10, SEM and deep-scanned EDS showed
that CaP were homogenously distributed throughout the surface of the chitosan coating. In
Figure 11 and 12 the SEM and EDS image illustrates that the CaP particles have been
incorporated throughout the full depth of the chitosan coating. In comparison to the standard
chitosan coating samples, the surface roughness of chitosan coating loaded with CaP nanoshells
was increased. This could be helpful in providing a larger surface area for contact between the
bone and the implant. The cross-section images from SEM/EDS (Figure 11 and 12) of the
chitosan coated samples indicated in-depth loading of CaP nanoshells.
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The electrosprayed, non-silanated coatings showed very low adhesive strengths
associated with simply physical adsorption phenomena. The adhesion strength of the silanated
coatings were 1.72 to 2.24 times that of the non-silanated coatings, confirming the formation of
chemical bonds between silane and chitosan as the main source of the adhesion strength. Table 4
indicates no statistical significance between 0.25, 0.5 and 1.0 wt % CaP loading with respect to
the standard chitosan coating (control). The tensile strength of the silanated control group was
compared to the reported values obtained by Chng in which the coatings produced had a tensile
strength of 5.87 MPa ± 2.03 MPa for electrosprayed, silanated chitosan on titanium. [52]
ANOVA showed that there were differences in coating adhesion between the program p< 0.001
and that post-hoc testing using Holm-Sidak showed that all silanated coatings had significantly
higher adhesion properties than the non-silanated but there was no statistically significant effect
of the amount of CaP nanoshells on coating adhesion strengths. However, the 1.0 wt% CaP was
close to be different from control silanated chitosan with a p=0.4. Based off the mean values, as
the loading percent of CaP nanoshells increases the strength of the chitosan coatings gradually
decreases. This could be because as the CaP nanoshells do not bond to the silane and hence as
the amount of nanoshells increase, there may be less bonding between the chitosan molecules
and the silane molecules on the surfaces.
All coatings were found to have water contact angles less than 90o indicating that the
coatings were hydrophilic. Previous studies have reported chitosan as hydrophilic, with chitosancoated surfaces having a contact angle of 76.4 ± 5.1°. [64] This is slightly higher to the values
obtained for this study’s chitosan coatings. The higher hydrophilicity in this study than others
might be due to differences in how coatings are treated to remove or neutralize residual acidic
acetate salts. Contact angle measurements did not identify any differences in hydrophilic
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properties between the plain chitosan coatings and the coatings containing CaP particles. It is
possible that the chitosan could be effectively covering the surface of the coatings hindering
major effects that the CaP shells would have on the coatings’ wettability. It was also observed
that addition of CaP nanoshells in the chitosan coating caused an increase in the standard
deviation of all coatings. This could be caused by an increase in surface roughness, possibly due
to the formation of CaP aggregates creating surface topography. This roughness can be observed
in Figure 9. Regardless, the hydrophilic characteristics of the coatings lead to a high degree of
cell attachment as indicated by cytoskeletal staining which showed very high numbers of cells on
the surfaces.
In the cell study all groups showed a high cell viability and attachment was observed at
the earliest time point to the coating. We theorize that this was majorly due to the
biocompatibility of chitosan coating towards cells and the structure of chitosan resembles
glycosaminoglycan, which is the key molecule in the extracellular matrix to modulate cell
morphology and function enhancing the cell attachment. [65] Also, earlier reports indicated that
calcium phosphate on alkaline chitosan coatings dissolve fast and released Ca ions stimulating
faster osteogenic cells. [66]
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CHAPTER IV
CONCLUSION
Our research shows that electrospraying technique can be used to successfully
electrospray chitosan with incorporated CaP nanoshells onto a Ti substrate. Our results indicate
that electrospraying technique can be utilized to incorporate up to a concentration of 1.0 wt%
CaP into chitosan solutions and still be sprayable. Using tensile testing it was found that there
was no statistically significant loss of coating adhesion strength in 0.25 wt%, 0.5 wt%, and 1.0
wt% CaP coatings. However, as the CaP percentage increased in the coatings the mean strength
of the coating did seem to decrease. Coatings were more hydrophilic than other reported chitosan
surfaces but contact angle measurements did not identify any differences in hydrophilic
properties between the plain chitosan coatings and the coatings containing CaP particles. The
incorporation of CaP did not significantly affect cell growth relative to plain chitosan coatings.
This work demonstrated that electrosprayed chitosan – CaP nanoshells are able to be bonded to
implant surfaces and are cytocompatible. These coatings may have potential to incorporate
therapeutic agents into the CaP nanoshells and or chitosan electrosprayed coatings for local drug
delivery to enhance osseointegration processes.
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CHAPTER V
FUTURE WORK AND RECOMMENDATION
The prominent factor in controlling the CaP particle size are the carbon nanosphere
precursors. Smaller carbon nanosphere precursors with a smaller size distribution would allow
for the creation of smaller CaP particles. This should help alleviate aggregate formation in the
electrospraying set up and help keep coating more uniform. More even distribution of CaP
throughout the coatings should cause less surface roughness.
With the decrease in spray pressure due to the larger capillary size, there arises an issue
of system throughput. The speed of the coating process is largely limited by single capillary
electrospray. This can be overcome using multi-nozzle electrospray set-ups to increase the spray
flowrate.
While ANOVA and post-hoc testing of the tensile testing showed all silanated coatings
had no statistically significant difference in strength with of the amount of CaP nanoshells on
coating adhesion strengths, the 1.0 wt% CaP was close to be different from control silanated
chitosan with a p=0.4. Furthermore, there was a noticeable mean decrease coating adhesion
strength as the CaP percentage increased. This is further noticed by the increased coating failure
area as the CaP percentage increases. It is recommended that additional tensile testing is
warranted to confirm if there is or is not an effect. It would also be recommended to examine the
degradation characteristics of the Chitosan CaP verses silanated and non-silanated titanium. If
the increase in CaP is shown to cause a decrease in coating adhesion, then a more aggressive
silanation process, such as, the piranha solution sanitation used by Martin et al, could be
investigated. [41] Otherwise, the titanium could be roughened to increase the surface area
between the chitosan and the substrate increasing bond strength.
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During the cellular compatibility testing, titanium samples were not used because
titanium has been tested before and chitosan has been shown to be comparable. Further studies
should be made comparing chitosan CaP coatings to other implant materials and coating such as
stainless steel and calcium phosphate.
The drug loading and release characteristics of the CaP nanoshell particles need to be
examined. Future studies may determine elution kinetics of antimicrobials, such as vancomycin
and amikacin since they are commonly used in the prophylaxis of complex musculoskeletal
trauma and in combination have activity against Gram positive and Gram negative bacteria.
Coating degradation may play a part in elution as the coatings degrade CaP particles inside the
coating will then be exposed to their surroundings. Whether this will increase the total elution
time or volume should be investigated.
Future studies should evaluate combination chitosan CaP coatings on titanium versus
both chitosan coated titanium and uncoated titanium will incorporate in vivo evaluations of
biocompatibility and osteointegration. A rodent model could be used to evaluate the safety of the
device when incorporated into a living system without infection present. If the chitosan CaP
coatings are proven to be biocompatible, its efficacy can be evaluated in an in vivo model of
infection prevention. Early studies will focus on preventing infection from occurring by placing
the delivery system alongside bacteria before they establish an infection.
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APPENDIX
Table 6: Two-Factor with Replication ANOVA for tensile testing of silanated vs test groups.
Source of Variation
Between Groups
Within Groups

SS
6.8791
47.03194

Total

53.91104

df
3
25

MS
2.293033
1.881278

F
1.21887

P-value
0.323487

F crit
2.991241

28

Table 7: Two-Factor with Replication ANOVA for tensile testing of non-silanated vs test
groups.
Source of Variation
Between Groups
Within Groups

SS
53.32641
29.01485

Total

82.34126

df
3
29

MS
F
17.77547 17.76637
1.000512

P-value
9.74E-07

F crit
2.93403

32

Table 8: All pairwise multiple comparison procedures Holm-Sidak post-hoc test of tensile test.
Overall significance level = 0.05.
Comparison
Es, Silanated vs. Es, Non-Silanated
CaP 0.25 wt% vs. Es, Non-Silanated
CaP 0.5 wt%, vs. Es, Non-Silanated
CaP 1.0 wt%, vs. Es, Non-Silanated
Es, Silanated vs. CaP 1.0 wt%,
CaP 0.25 wt% vs. CaP 1.0 wt%,
Es, Silanated vs. CaP 0.5 wt%,
CaP 0.5 wt%, vs. CaP 1.0 wt%,
CaP 0.25 wt% vs. CaP 0.5 wt%,
Es, Silanated vs. CaP 0.25 wt%

Diff of
Means
3.115
2.98
2.463
1.802
1.313
1.178
0.652
0.661
0.517
0.135

60

t

P

P<0.050

6.607
5.042
4.168
2.849
1.998
1.575
1.056
0.884
0.725
0.219

<0.001
<0.001
0.001
0.047
0.277
0.481
0.756
0.764
0.722
0.828

Yes
Yes
Yes
Yes
No
No
No
No
No
No

Table 9: Two-Factor with Replication ANOVA for Cell study.
Source of
Variation
Sample
Columns
Interaction
Within

SS
4.97E+13
1.71E+12
1.56E+12
5.53E+11

Total

5.35E+13

df
2
4
8
30

MS
2.48E+13
4.28E+11
1.95E+11
1.84E+10

F
1346.751
23.23018
10.5887

P-value
4.26E-30
8.01E-09
6.44E-07

F crit
3.31583
2.689628
2.266163
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A result of "Do Not Test" occurs for a comparison when no significant difference is
found between two means that enclose that comparison. It should be noted that not testing the
enclosed means is a procedural rule, and a result of Do Not Test should be treated as if there is
no significant difference between the means, even though one may appear to exist.
Table 10: Day 1 pairwise multiple comparison procedures (Student-Newman-Keuls Method)
post-hoc test of tensile test. Overall significance level = 0.05.
Comparison

Diff of
Means
54100
53501.67
22060
7549.667
46550.33
45952
14510.33
32040
31441.67
598.333

Ti-CH vs. Control (TCP)
Ti-CH vs. TiCH 1.0 wt% CaP
Ti-CH vs. TiCH 0.5 wt% CaP
Ti-CH vs. TiCH 0.25 wt% CaP
TiCH 0.25 wt% CaP vs. Control (TCP)
TiCH 0.25 wt% CaP vs. TiCH 1.0 wt% CaP
TiCH 0.25 wt% CaP vs. TiCH 0.5 wt% CaP
TiCH 0.5 wt% CaP vs. Control (TCP)
TiCH 0.5 wt% CaP vs. TiCH 1.0 wt% CaP
TiCH 1.0 wt% CaP vs. Control (TCP)

61

p

q

5 5.999
4 5.932
3 2.446
2 0.837
4 5.162
3 5.095
2 1.609
3 3.553
2 3.486
2 0.0663

P

P<0.050

0.012
0.009
0.242
0.567
0.02
0.012
0.282
0.073
0.034
0.964

Yes
Yes
No
Do Not Test
Yes
Yes
Do Not Test
No
Do Not Test
Do Not Test

Table 11: Day 3 pairwise multiple comparison procedures (Student-Newman-Keuls Method)
post-hoc test of tensile test. Overall significance level = 0.05.
Comparison
Control (TCP) vs. TiCH 0.5 wt% CaP
Control (TCP) vs. TiCH 0.25 wt% CaP
Control (TCP) vs. TiCH 1.0 wt% CaP
Control (TCP) vs. Ti-CH
Ti-CH vs. TiCH 0.5 wt% CaP
Ti-CH vs. TiCH 0.25 wt% CaP
Ti-CH vs. TiCH 1.0 wt% CaP
TiCH 1.0 wt% CaP vs. TiCH 0.5 wt% CaP
TiCH 1.0 wt% CaP vs. TiCH 0.25 wt% CaP
TiCH 0.25 wt% CaP vs. TiCH 0.5 wt% CaP

Diff of
Means
675232.333
504200.667
287447.333
158560.333
516672
345640.333
128887
387785
216753.333
171031.667

p

q

P

5 18.92 <0.001
4 14.127 <0.001
3 8.054 <0.001
2 4.443 0.011
4 14.477 <0.001
3 9.685 <0.001
2 3.611 0.029
3 10.866 <0.001
2 6.073 0.002
2 4.792 0.007

P<0.050
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Table 12: Day 5 pairwise multiple comparison procedures (Student-Newman-Keuls Method)
post-hoc test of tensile test. Overall significance level = 0.05.
Comparison
Control (TCP) vs. TiCH 0.25 wt% CaP
Control (TCP) vs. TiCH 0.5 wt% CaP
Control (TCP) vs. Ti-CH
Control (TCP) vs. TiCH 1.0 wt% CaP
TiCH 1.0 wt% CaP vs. TiCH 0.25 wt% CaP
TiCH 1.0 wt% CaP vs. TiCH 0.5 wt% CaP
TiCH 1.0 wt% CaP vs. Ti-CH
Ti-CH vs. TiCH 0.25 wt% CaP
Ti-CH vs. TiCH 0.5 wt% CaP
TiCH 0.5 wt% CaP vs. TiCH 0.25 wt% CaP

Diff of
Means
1238673.667
790774.333
731031.667
572468
666205.667
218306.333
158563.667
507642
59742.667
447899.333

62

p

q

P

P<0.050

5
4
3
2
4
3
2
3
2
2

9.475
6.049
5.592
4.379
5.096
1.67
1.213
3.883
0.457
3.426

<0.001
0.008
0.007
0.011
0.021
0.49
0.411
0.05
0.753
0.036

Yes
Yes
Yes
Yes
Yes
No
Do Not Test
Yes
Do Not Test
Yes

